Publication | Open Access

A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon α and interleukin-2 efficiently retargets T and CD3 + CD56 + natural-killer-like T lymphocytes to EpCAM-expressing tumor cells

Cancer ImmunosurveillanceImmunologyTumor ImmunityImmunodominanceImmune RegulationImmune SurveillanceAntigen ProcessingHumoral ImmunityCd4 T Cell ResponsesImmunotherapeuticsT Cell ImmunityBispecific Single-chain AntibodyCellular Immune ResponseImmunotherapyMedicineCell BiologyEpcam-expressing Tumor Cells